Ethical Guidance for Selecting Clinical Trials to Receive Limited Space in an Immunotherapy Production Facility
Ethical Guidance for Selecting Clinical Trials to Receive Limited Space in an Immunotherapy Production Facility
复制标题
DOI：
10.1080/15265161.2018.1444817
复制
发表时间：
2018-01-01
影响因子：
13.4
通讯作者：
Diekema, Douglas S.
中科院分区：
文献类型：
--
作者：
Jecker, Nancy S.;Wightman, Aaron G.;Diekema, Douglas S.
我们的目标是：（1）提出一个多原则系统，用于在竞争有限空间的免疫治疗生产设施中进行选择，该设施提供科学调查人员正在调查的产品;（2）通过诉诸正义原则来捍卫这个系统;（3）通过展示如何实施我们的建议来说明我们的建议。我们的首要目标是帮助免疫产品和其他潜在突破性实验疗法的制造商在生产能力有限的情况下优先考虑科学研究人员的要求。
Our aims are to (1) set forth a multiprinciple system for selecting among clinical trials competing for limited space in an immunotherapy production facility that supplies products under investigation by scientific investigators; (2) defend this system by appealing to justice principles; and (3) illustrate our proposal by showing how it might be implemented. Our overarching aim is to assist manufacturers of immunotherapeutic products and other potentially breakthrough experimental therapies with the ethical task of prioritizing requests from scientific investigators when production capacity is limited.